Postoperative serum CHI3L1 level is associated with postoperative cognitive dysfunction in elderly patients after hip fracture surgery: A prospective observational study

被引:1
作者
Zheng, Huiwen [1 ,2 ]
Chen, Qianmin [1 ]
Zhang, Jingyue [1 ,2 ]
Ren, Baiqing [1 ,2 ]
Liu, Tianya [1 ]
Liu, Chao [1 ,2 ]
Wang, Xiaoye [2 ]
Sheng, Jingyi [1 ,2 ]
Wang, Zhiping [1 ,2 ,3 ,4 ]
机构
[1] Xuzhou Med Univ, Affiliated Hosp, Dept Anesthesiol, Xuzhou, Jiangsu, Peoples R China
[2] Xuzhou Med Univ, Xuzhou, Jiangsu, Peoples R China
[3] Xuzhou Med Univ, Jiangsu Prov Key Lab Anesthesiol, 209 Tongshan Rd, Xuzhou, Jiangsu, Peoples R China
[4] Xuzhou Med Univ, Affiliated Hosp, Dept Anesthesiol, Xuzhou 221006, Jiangsu, Peoples R China
基金
中国国家自然科学基金;
关键词
Postoperative cognitive dysfunction; Geriatric; Chitinase-3-like-1; Interleukin; C -reactive protein; Total hip arthroplasty; ALZHEIMERS-DISEASE; YKL-40; BIOMARKER; INFLAMMATION;
D O I
10.1016/j.heliyon.2023.e18796
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Objectives: Postoperative cognitive dysfunction (POCD) is a common postoperative complication in older patients. Chitinase-3-like-1 protein (CHI3L1) is identified as a neuroinflammatory biomarker and impairs cognitive function. This study aimed to evaluate the association between serum levels of CHI3L1 and POCD and explore the levels of interleukin-6 (IL-6), IL-1 ss and Creactive protein (CRP) in the elderly after total hip arthroplasty (THA). Patients and methods: A total of 76 elderly patients undergoing THA were enrolled in the prospective observational study. Serum CHI3L1 levels were measured 1 day before and 1 day after surgery and other perioperative factors were also noted. The correlations between mediators of inflammation in the two groups were compared via Spearman correlation coefficients. The receiver operating characteristic (ROC) curves were implemented to analyze the predictive values of serum CHI3L1 and other inflammatory factors for POCD. And factors associated with POCD were analyzed by univariate and multivariate logistics. Results: POCD was observed in 31.6% of patients 1 week after surgery. Postoperative serum CHI3L1 levels were higher in POCD patients than in non-POCD patients [1348.26 (778.46-1889.77) VS 2322.86(1686.88-2517.35) ng/ml, P < 0.001]. Postoperative serum CHI3L1 level was positively correlated with postoperative IL-6 level (r = 0.284, P = 0.013). Compared with IL-6, IL-1 ss, and CRP, postoperative CHI3L1 level has the highest predictive value for POCD with the area under the curve (AUC) value of 0.779 according to the ROC curve. By the multivariate logistic regression analysis, elevated postoperative serum CHI3L1 level was found to be an independent risk factor for POCD 1 week after surgery (odds ratio = 1.204, 95% confidence interval = 1.087-1.332, P = 0.001). Conclusion: Postoperative elevated serum CHI3L1 level was significantly associated with the incident of POCD, and positively correlated with postoperative IL-6 level in the elderly after THA. This biomarker may have potential utility for further elucidating the etiology of POCD.
引用
收藏
页数:11
相关论文
共 46 条
  • [1] Cerebrospinal Fluid Level of YKL-40 Protein in Preclinical and Prodromal Alzheimer's Disease
    Antonell, Anna
    Mansilla, Alicia
    Rami, Lorena
    Llado, Albert
    Iranzo, Alex
    Olives, Jaume
    Balasa, Mircea
    Sanchez-Valle, Raquel
    Luis Molinuevo, Jose
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2014, 42 (03) : 901 - 908
  • [2] Postoperative cognitive dysfunction, Alzheimer's disease, and anesthesia
    Arora, Sona S.
    Gooch, Jennifer L.
    Garcia, Paul S.
    [J]. INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2014, 124 (04) : 236 - 242
  • [3] The neuroinflammatory biomarker YKL-40 for neurodegenerative diseases: advances in development
    Baldacci, Filippo
    Lista, Simone
    Palermo, Giovanni
    Giorgi, Filippo Sean
    Vergallo, Andrea
    Hampel, Harald
    [J]. EXPERT REVIEW OF PROTEOMICS, 2019, 16 (07) : 593 - 600
  • [4] Diagnostic function of the neuroinflammatory biomarker YKL-40 in Alzheimer's disease and other neurodegenerative diseases
    Baldacci, Filippo
    Lista, Simone
    Cavedo, Enrica
    Bonuccelli, Ubaldo
    Hampel, Harald
    [J]. EXPERT REVIEW OF PROTEOMICS, 2017, 14 (04) : 285 - 299
  • [5] In vivo CHI3L1 (YKL-40) expression in astrocytes in acute and chronic neurological diseases
    Bonneh-Barkay, Dafna
    Wang, Guoji
    Starkey, Adam
    Hamilton, Ronald L.
    Wiley, Clayton A.
    [J]. JOURNAL OF NEUROINFLAMMATION, 2010, 7
  • [6] Chitinase 3-like 1: prognostic biomarker in clinically isolated syndromes
    Canto, Ester
    Tintore, Mar
    Villar, Luisa M.
    Costa, Carme
    Nurtdinov, Ramil
    Alvarez-Cermeno, Jose C.
    Arrambide, Georgina
    Reverter, Ferran
    Deisenhammer, Florian
    Hegen, Harald
    Khademi, Mohsen
    Olsson, Tomas
    Tumani, Hayrettin
    Rodriguez-Martin, Eulalia
    Piehl, Fredrik
    Bartos, Ales
    Zimova, Denisa
    Kotoucova, Jolana
    Kuhle, Jens
    Kappos, Ludwig
    Antonio Garcia-Merino, Juan
    Jos Sanchez, Antonio
    Saiz, Albert
    Blanco, Yolanda
    Hintzen, Rogier
    Jafari, Naghmeh
    Brassat, David
    Lauda, Florian
    Roesler, Romy
    Rejdak, Konrad
    Papuc, Ewa
    de Andres, Clara
    Rauch, Stefan
    Khalil, Michael
    Enzinger, Christian
    Galimberti, Daniela
    Scarpini, Elio
    Teunissen, Charlotte
    Sanchez, Alex
    Rovira, Alex
    Montalban, Xavier
    Comabella, Manuel
    [J]. BRAIN, 2015, 138 : 918 - 931
  • [7] Pain and the Montreal Cognitive Assessment (MoCA) in Aging
    Cardoso, Josue
    Apagueno, Brandon
    Lysne, Paige
    Hoyos, Lorraine
    Porges, Eric
    Riley, Joseph L.
    Fillingim, Roger B.
    Woods, Adam J.
    Cohen, Ronald
    Cruz-Almeida, Yenisel
    [J]. PAIN MEDICINE, 2021, 22 (08) : 1776 - 1783
  • [8] An evaluation on the neuropsychological tests used in the assessment of postchemotherapy cognitive changes in breast cancer survivors
    Cheung, Yin Ting
    Tan, Earl Hsien-Jie
    Chan, Alexandre
    [J]. SUPPORTIVE CARE IN CANCER, 2012, 20 (07) : 1361 - 1375
  • [9] K284-6111 prevents the amyloid beta-induced neuroinflammation and impairment of recognition memory through inhibition of NF-κB-mediated CHI3L1 expression
    Choi, Ji Yeon
    Yeo, In Jun
    Kim, Ki Cheon
    Choi, Won Rack
    Jung, Jae-Kyung
    Han, Sang-Bae
    Hong, Jin Tae
    [J]. JOURNAL OF NEUROINFLAMMATION, 2018, 15
  • [10] YKL-40: A Novel Prognostic Fluid Biomarker for Preclinical Alzheimer's Disease
    Craig-Schapiro, Rebecca
    Perrin, Richard J.
    Roe, Catherine M.
    Xiong, Chengjie
    Carter, Deborah
    Cairns, Nigel J.
    Mintun, Mark A.
    Peskind, Elaine R.
    Li, Ge
    Galasko, Douglas R.
    Clark, Christopher M.
    Quinn, Joseph F.
    D'Angelo, Gina
    Malone, James P.
    Townsend, R. Reid
    Morris, John C.
    Fagan, Anne M.
    Holtzman, David M.
    [J]. BIOLOGICAL PSYCHIATRY, 2010, 68 (10) : 903 - 912